Bluejay Therapeutics Email Format
Biotechnology ResearchSan Francisco Bay Area, United States11-50 Employees
The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.